Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Altman

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Molecular Cancer Therapeutics|November 24, 2006
Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cellsPatrick Yoon, Nick Giafis, Jessica Smith, et al.
The American Surgeon|June 12, 2026
Transportation Access as a Structural Determinant of Firearm ViolenceJessica Altman, Alexandra Campbell, Ethan Smith, et al.
Genes, Chromosomes & Cancer|October 20, 2021
Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activationJuehua Gao, Sandeep Gurbuxani, Taylor Zak, et al.
Cancer Research|October 6, 2005
Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromesEfstratios Katsoulidis, Yongzhong Li, Patrick Yoon, et al.
Blood Neoplasia|September 11, 2025
Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AMLAdam Y Lin, Jonathan S Rink, Eva Yang, et al.
Leukemia & Lymphoma|July 16, 2009
Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantationJayesh Mehta, Jayesh Mehta, Olga Frankfurt, et al.
Blood Advances|March 19, 2024
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemiaMark Levis, Alexander Perl, Gary Schiller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2012
Chronic myelogenous leukemiaSusan O'Brien, Camille N Abboud, Mojtaba Akhtari, et al.
JACC. Advances|June 18, 2026
Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort StudySabin Filimon, Azin Ghamari, Azin Vakilpour, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2011
Acute myeloid leukemiaMargaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|November 24, 2006
Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cellsPatrick Yoon, Nick Giafis, Jessica Smith, et al.
The American Surgeon|June 12, 2026
Transportation Access as a Structural Determinant of Firearm ViolenceJessica Altman, Alexandra Campbell, Ethan Smith, et al.
Genes, Chromosomes & Cancer|October 20, 2021
Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activationJuehua Gao, Sandeep Gurbuxani, Taylor Zak, et al.
Cancer Research|October 6, 2005
Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromesEfstratios Katsoulidis, Yongzhong Li, Patrick Yoon, et al.
Blood Neoplasia|September 11, 2025
Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AMLAdam Y Lin, Jonathan S Rink, Eva Yang, et al.
Leukemia & Lymphoma|July 16, 2009
Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantationJayesh Mehta, Jayesh Mehta, Olga Frankfurt, et al.
Blood Advances|March 19, 2024
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemiaMark Levis, Alexander Perl, Gary Schiller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2012
Chronic myelogenous leukemiaSusan O'Brien, Camille N Abboud, Mojtaba Akhtari, et al.
JACC. Advances|June 18, 2026
Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort StudySabin Filimon, Azin Ghamari, Azin Vakilpour, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2011
Acute myeloid leukemiaMargaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Pageof 3